Le Lézard
Classified in: Health
Subject: LEG

Physicians say Pa. court rule could bring back 'venue shopping' and jeopardize patient access to care


HARRISBURG, Pa., Jan. 17, 2019 /PRNewswire/ -- A proposed rule change from the Pa. Supreme Court could usher the return of skyrocketing medical liability premiums for physicians and threaten patient access to quality care, says the Pennsylvania Medical Society (PAMED).

Escalating medical liability premiums created a crisis in Pennsylvania when the state lost approximately 10 percent of its physicians between 1997-2000. Reforms by the state legislature and court system in 2002 stabilized the medical liability insurance market and reversed the crisis.

However, the Pa. Supreme Court recently proposed to eliminate one of the key pieces of those reforms.

Currently, medical liability claims can only stand trial in the county where the alleged medical error occurred. The rule change would eliminate this restriction and allow attorneys to move medical liability claims to counties that award higher payoffs ? a practice known as "venue shopping."

The proposed rule is open for public comments between now and Feb. 22. The court argues that venue restrictions are no longer necessary because Pennsylvania's physicians no longer face skyrocketing medical liability rates.

A coalition that includes PAMED, the Hospital and Healthsystem Association of Pennsylvania (HAP), and the Pennsylvania Coalition for Civil Justice Reform (PCCJR) says the venue rule was one of the primary reasons the medical liability market has stabilized during the past 15 years.

"If history is any indication, this could have devastating effects on patient care," said Danae Powers, MD, president of PAMED. "In the years before we restricted venue shopping, medical liability premiums rose so quickly that some physicians couldn't obtain the insurance they needed to treat patients. Others chose to leave Pennsylvania or retire."

A shrinking physician workforce made it more difficult for patients to get care, says Dr. Powers, especially among "high-risk" physicians such as OB-GYNs and surgeons.

"This rule change ignores history and puts new mothers, older Pennsylvanians and anyone needing a specialist at risk of losing access to quality health care," said Curt Schroder, Executive Director at PCCJR. "The practice of venue shopping was an integral part of a health care crisis in Pennsylvania before and should this rule change be adopted, we run the risk of repeating history."

Nathan Hoff, a third-year medical student from Scranton, says the rule change would increase the chances that medical students and physician residents would seek employment in other states after graduating.

"While you may have already heard from many physicians, this issue is also important to medical students and residents, such as myself," said Hoff, who is chair of PAMED's Medical Student Section. "This is very likely to cause future generations of physicians to seek employment opportunities outside of Pennsylvania, leaving the state with less physicians and adversely affecting patient care."

The Pa. Supreme Court's Civil Procedural Rules Committee, which is proposing the change, is comprised of lawyers.

More information: www.pamedsoc.org/VenueRule

About Pennsylvania Medical Society
The Pennsylvania Medical Society helps its 21,000 physician and medical student members return to the art of medicine through advocacy and education. To learn more, visit www.pamedsoc.org or follow us on Twitter at @PAMEDSociety.

 

SOURCE Pennsylvania Medical Society


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: